Vitamin D and bone health

â??Vitamin D Status and bone micro-architecture in asymptomatic healthy females and healthy males, effect of vitamin D on Trabecular bone scoreâ??

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/044030

Enrollment

Registered

2022-07-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: cholecalciferol sachet (60000 IU ) and shelcal tablet (500mg): cholecalciferol 60000 one sachet once a week for 8 weeks followed by one sachet once a month for next 10 months and shelca

Eligibility

Inclusion criteria

Inclusion criteria: Apparently healthy subjects with serum 25(OH)D less than 20 ng/ml, TBS less than 1.310.

Exclusion criteria

Exclusion criteria: More than 60 years, less than 20 years of age, serum 25(OH) more than 20 ng/ml. Subjects with co morbid condition like history of use of antitubercular, antiepileptic drugs or indigenous medicine for more than three months during past six months

Design outcomes

Primary

Measure	Time frame
Improvement in trabecular bone score with cholecalciferol and Calcium supplementationTimepoint: Trabecular bone score will be measured at baseline, at 6 months and 12 months after cholecalciferol and Calcium supplementation	—

Secondary

Measure	Time frame
Trend in BMDTimepoint: At six months and one year.	—

Countries

India

Contacts

Public ContactDr Anand Vishal

All India Institute of Medical Sciences, New Delhi

gosravinder@hotmail.com9818130879

Outcome results